Sep 10, 2021 | Access, Actions, Federal Issues, Medicare
There is a constant drum beat around the rising cost of drug prices, with little discussion of the benefit design in plans whether they are government or employer sponsored. Medicare Part B requires patients without supplemental coverage to pay a 20% copay on all...
Read more
Jan 30, 2021 | Featured, Medicare
On this episode of the podcast, Terry and Bob discuss drug pricing in Washington D.C. There are many potential paths that drug pricing reform may take in the next couple of years with competing pieces of legislation in the House of Representatives and the Senate. They...
Read more
Dec 26, 2020 | Featured, Federal Issues, Medicare, Podcast
On this episode of the podcast, Terry and Bob discuss President Trump’s “most favored nations” rule which ties federal reimbursements for Medicare Part B drugs to other developed nations’ prices. In other words, this rule is a de facto price...
Read more
